Ledger.Open graph →
SEC Form D · filed July 12, 2019

Esperance Pharmaceuticals, Inc

Offering
$1.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HOUSTON, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Peter Hoang · JACKSONVILLE, FLDirectorHector Alila · Houston, TXExec · DirectorRoss Barrett · Sudbury, MADirectorJoseph Lovett · Sudbury, MADirectorPeter Hoang · JACKSONVILLE, FLDirectorSonia Deggs · Houston, TXExecCarola Leuschner · Houston, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗